I agree that this site is using cookies. You can find further informations here.
X
Moscetti, L.
468  results:
Search for persons X
?
1

318P Pattern of expression, transcriptional states and clin..:

Salati, M. ; Quitadamo, M.P.F. ; Moscetti, L....
Annals of Oncology.  35 (2024)  - p. S133-S134 , 2024
Link: https://doi.org/10.1016/..
 
?
2

285P Survivorship care plans and recurrence detection in br..:

Belluzzi, L. ; Natalizio, S. ; Medici, B....
ESMO Open.  9 (2024)  - p. 103343 , 2024
Link: https://doi.org/10.1016/..
 
?
3

208P Clinicopathological factors and treatment management i..:

Ponzoni, O. ; Antonelli, G. ; Martinelli, G....
ESMO Open.  9 (2024)  - p. 103230 , 2024
Link: https://doi.org/10.1016/..
 
?
4

225P Platinum-based chemotherapy and PARP Inhibitors for BR..:

Valenza, C. ; Trapani, D. ; Sposetti, C....
ESMO Open.  8 (2023)  1 - p. 101414 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P120 Cardiac safety of pertuzumab, trastuzumab and standard..:

Canino, F. ; Barbolini, M. ; De Giorgi, U....
The Breast.  68 (2023)  - p. S60 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Are you treating ypN0 patient with adjuvant abemaciclib?:

Toss, A. ; Moscetti, L.
ESMO Open.  8 (2023)  3 - p. 101217 , 2023
Link: https://doi.org/10.1016/..
 
?
7

POSC248 Real-World Patient Characteristics and Treatment Pa..:

Malapelle, U ; Giannopoulou, M ; Moscetti, A..
Value in Health.  25 (2022)  1 - p. S167-S168 , 2022
Link: https://doi.org/10.1016/..
 
?
8

The European Medicines Agency review of the initial applica..:

Araujo-Fernandez, I. ; Delgado, J. ; Moscetti, L....
ESMO Open.  6 (2021)  1 - p. 100008 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Two-month stop in mammographic screening significantly impa..:

Toss, A. ; Isca, C. ; Venturelli, M....
ESMO Open.  6 (2021)  2 - p. 100055 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Quality of life of therapies for hormone receptor positive ..:

Moscetti, L. ; Sperduti, I. ; Frassoldati, A....
The Breast.  59 (2021)  - p. 232-238 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Safety analysis, association with response and previous tre..:

Moscetti, L. ; Vici, P. ; Gamucci, T....
The Breast.  29 (2016)  - p. 96-101 , 2016
Link: https://doi.org/10.1016/..
 
?
12

1950 Predictive factors of response to neoadjuvant chemothe..:

Gamucci, T. ; Mentuccia, L. ; Vici, P....
European Journal of Cancer.  51 (2015)  - p. S315 , 2015
Link: https://doi.org/10.1016/..
 
?
13

1851 Safety analysis, correlation with response and previou..:

Moscetti, L. ; Vici, P. ; Sperduti, I....
European Journal of Cancer.  51 (2015)  - p. S282-S283 , 2015
Link: https://doi.org/10.1016/..
 
?
14

The distribution of KIR‐HLA functional blocks is different ..:

Fasano, M. E. ; Rendine, S. ; Pasi, A....
Tissue Antigens.  83 (2014)  3 - p. 168-173 , 2014
Link: https://doi.org/10.1111/..
 
?
15

A novel HLA-B*18:80 allele identified by SBT typing in an I..:

Lochmann, E. ; Frison, S. ; Longhi, E...
International Journal of Immunogenetics.  41 (2014)  3 - p. 262-263 , 2014
Link: https://doi.org/10.1111/..
 
1-15